Somatostatin Receptor Subtype Expression in Patients with Acromegaly and Complicated Clinical Course

Somatostatin analogues are considered to be the first line of treatment in acromegaly. Somatostatin analogues of the first generation mainly target the somatostatin receptor (SSTR) subtype 2 and have been proven efficient in the majority of patients with acromegaly. Pasireotide was the first somatos...

Descripción completa

Detalles Bibliográficos
Autores principales: Pichler, Robert, Kalev, Ognian, Tomancok, Berndt, Sonnberger, Michael, Ehrlich, Daniela, Hodolic, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228866/
https://www.ncbi.nlm.nih.gov/pubmed/34200337
http://dx.doi.org/10.3390/diagnostics11061050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228866/
https://www.ncbi.nlm.nih.gov/pubmed/34200337
http://dx.doi.org/10.3390/diagnostics11061050

Ejemplares similares